{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:33:21Z","timestamp":1790469201611,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"vor","delay-in-days":640,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM116184"],"award-info":[{"award-number":["GM116184"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM121601"],"award-info":[{"award-number":["GM121601"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM12275"],"award-info":[{"award-number":["GM12275"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P30GM114731"],"award-info":[{"award-number":["P30GM114731"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19AI062629"],"award-info":[{"award-number":["U19AI062629"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1111\/jth.15162","type":"journal-article","created":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T01:44:38Z","timestamp":1605059078000},"page":"429-443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["CD14 inhibition improves survival and attenuates thrombo\u2010inflammation and cardiopulmonary dysfunction in a baboon model of Escherichia coli sepsis"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4177-9095","authenticated-orcid":false,"given":"Ravi S.","family":"Keshari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9590-6160","authenticated-orcid":false,"given":"Robert","family":"Silasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4809-9885","authenticated-orcid":false,"given":"Narcis I.","family":"Popescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6827-3783","authenticated-orcid":false,"given":"Girija","family":"Regmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7112-564X","authenticated-orcid":false,"given":"Hala","family":"Chaaban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9370-5776","authenticated-orcid":false,"given":"John D.","family":"Lambris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8619-0893","authenticated-orcid":false,"given":"Cristina","family":"Lupu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5785-802X","authenticated-orcid":false,"given":"Tom E.","family":"Mollnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1249-9278","authenticated-orcid":false,"given":"Florea","family":"Lupu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.15162_bb0010","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1172\/JCI200319523","article-title":"The enigma of sepsis","volume":"112","author":"Riedemann","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.15162_bb0015","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nm0503-517","article-title":"Novel strategies for the treatment of sepsis","volume":"9","author":"Riedemann","year":"2003","journal-title":"Nat Med"},{"key":"10.1111\/jth.15162_bb0020","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00024382-200116020-00001","article-title":"Sepsis syndromes: understanding the role of innate and acquired immunity","volume":"16","author":"Oberholzer","year":"2001","journal-title":"Shock"},{"issue":"7","key":"10.1111\/jth.15162_bb0025","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2017.36","article-title":"The immunopathology of sepsis and potential therapeutic targets","volume":"17","author":"van der Poll","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/jth.15162_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/CS20100539","article-title":"Role of toll\u2010like receptors in cardiovascular diseases","volume":"121","author":"Vallejo","year":"2011","journal-title":"Clin Sci (Lond)"},{"key":"10.1111\/jth.15162_bb0035","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0009-8981(02)00180-8","article-title":"Initial responses to endotoxins and Gram\u2010negative bacteria","volume":"323","author":"Heumann","year":"2002","journal-title":"Clin Chim Acta"},{"key":"10.1111\/jth.15162_bb0040","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S1286-4579(02)01613-1","article-title":"Toll receptors, CD14, and macrophage activation and deactivation by LPS","volume":"4","author":"Dobrovolskaia","year":"2002","journal-title":"Microbes Infect"},{"key":"10.1111\/jth.15162_bb0045","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1111\/j.1582-4934.2010.01127.x","article-title":"Endogenous toll\u2010like receptor ligands and their biological significance","volume":"14","author":"Yu","year":"2010","journal-title":"J Cell Mol Med"},{"key":"10.1111\/jth.15162_bb0050","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00134-016-4607-x","article-title":"Should all septic patients be given systemic anticoagulation? No","volume":"43","author":"van der Poll","year":"2017","journal-title":"Intensive Care Med"},{"key":"10.1111\/jth.15162_bb0055","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/jama.2013.2194","article-title":"Effect of eritoran, an antagonist of MD2\u2010TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial","volume":"309","author":"Opal","year":"2013","journal-title":"JAMA"},{"key":"10.1111\/jth.15162_bb0060","doi-asserted-by":"crossref","first-page":"13875","DOI":"10.1073\/pnas.95.23.13875","article-title":"Anti\u2010CD14 mAb treatment provides therapeutic benefit after in vivo exposure to endotoxin","volume":"95","author":"Schimke","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.15162_bb0065","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejphar.2017.03.027","article-title":"Anti\u2010human CD14 monoclonal antibody improves survival following sepsis induced by endotoxin, but not following polymicrobial infection","volume":"806","author":"Nakamura","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/jth.15162_bb0070","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1172\/JCI118945","article-title":"Antibodies against CD14 protect primates from endotoxin\u2010induced shock","volume":"98","author":"Leturcq","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.15162_bb0075","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1096\/fj.09-140798","article-title":"CD14 inhibition efficiently attenuates early inflammatory and hemostatic responses in Escherichia coli sepsis in pigs","volume":"24","author":"Thorgersen","year":"2009","journal-title":"FASEB J"},{"key":"10.1111\/jth.15162_bb0080","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1128\/IAI.69.4.2099-2106.2001","article-title":"Critical role of CD14 for production of proinflammatory cytokines and cytokine inhibitors during sepsis with failure to alter morbidity or mortality","volume":"69","author":"Ebong","year":"2001","journal-title":"Infect Immun"},{"key":"10.1111\/jth.15162_bb0085","first-page":"158","article-title":"van Deventer SJ, van der PT. Effect of IC14, an anti\u2010CD14 antibody, on plasma and cell\u2010associated chemokines during human endotoxemia","volume":"14","author":"Olszyna","year":"2003","journal-title":"Eur Cytokine Netw"},{"key":"10.1111\/jth.15162_bb0090","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1086\/346043","article-title":"Effects of IC14, an anti\u2010CD14 antibody, on coagulation and fibrinolysis during low\u2010grade endotoxemia in humans","volume":"187","author":"Verbon","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1111\/jth.15162_bb0095","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.4049\/jimmunol.179.9.6107","article-title":"TLR4\/MD\u20102 monoclonal antibody therapy affords protection in experimental models of septic shock","volume":"179","author":"Daubeuf","year":"2007","journal-title":"J Immunol"},{"key":"10.1111\/jth.15162_bb0100","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejphar.2017.02.045","article-title":"Simultaneous targeting of CD14 and factor XIa by a fusion protein consisting of an anti\u2010CD14 antibody and the modified second domain of bikunin improves survival in rabbit sepsis models","volume":"802","author":"Nakamura","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/jth.15162_bb0105","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1186\/s13054-015-1129-9","article-title":"Combined inhibition of complement and CD14 improved outcome in porcine polymicrobial sepsis","volume":"19","author":"Skjeflo","year":"2015","journal-title":"Crit Care"},{"key":"10.1111\/jth.15162_bb0110","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1097\/01.CCM.0000124870.42312.C4","article-title":"CD14 receptor occupancy in severe sepsis: results of a phase I clinical trial with a recombinant chimeric CD14 monoclonal antibody (IC14)","volume":"32","author":"Reinhart","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1111\/jth.15162_bb0115","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1582-4934.2011.01454.x","article-title":"Pathophysiology, staging and therapy of severe sepsis in baboon models","volume":"16","author":"Taylor","year":"2012","journal-title":"J Cell Mol Med"},{"key":"10.1111\/jth.15162_bb0120","series-title":"Guide for the Care and Use of Laboratory Animals","author":"Council","year":"2011"},{"key":"10.1111\/jth.15162_bb0125","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1182\/bloodadvances.2018029983","article-title":"Inhibition of contact\u2010mediated activation of factor XI protects baboons against S aureus\u2010induced organ damage and death","volume":"3","author":"Silasi","year":"2019","journal-title":"Blood Adv"},{"key":"10.1111\/jth.15162_bb0130","doi-asserted-by":"crossref","first-page":"E6390","DOI":"10.1073\/pnas.1706818114","article-title":"Inhibition of complement C5 protects against organ failure and reduces mortality in a baboon model of Escherichia coli sepsis","volume":"114","author":"Keshari","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.15162_bb0135","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1128\/IAI.00390-13","article-title":"Systemic CD14 inhibition attenuates organ inflammation in porcine Escherichia coli sepsis","volume":"81","author":"Thorgersen","year":"2013","journal-title":"Infect Immun"},{"key":"10.1111\/jth.15162_bb0140","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1182\/blood-2010-02-269746","article-title":"Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of Escherichia coli sepsis","volume":"116","author":"Silasi\u2010Mansat","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.15162_bb0145","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1182\/blood.V95.5.1680.005k33_1680_1686","article-title":"The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis","volume":"95","author":"Taylor","year":"2000","journal-title":"Blood"},{"key":"10.1111\/jth.15162_bb0150","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.2353\/ajpath.2007.070104","article-title":"Sepsis\u2010induced coagulation in the baboon lung is associated with decreased tissue factor pathway inhibitor","volume":"171","author":"Tang","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1111\/jth.15162_bb0155","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMra021333","article-title":"The pathophysiology and treatment of sepsis","volume":"348","author":"Hotchkiss","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.15162_bb0160","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrd1084","article-title":"Such stuff as dreams are made on: mediator\u2010directed therapy in sepsis","volume":"2","author":"Marshall","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1111\/jth.15162_bb0165","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/nm0712-997","article-title":"Focus on sepsis","volume":"18","year":"2012","journal-title":"Nat Med"},{"key":"10.1111\/jth.15162_bb0170","doi-asserted-by":"crossref","first-page":"35237","DOI":"10.1074\/jbc.R114.619304","article-title":"Complexity of danger: the diverse nature of damage\u2010associated molecular patterns","volume":"289","author":"Schaefer","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.15162_bb0175","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1161\/01.ATV.17.8.1550","article-title":"Intracellular calcium mobilization suppresses the TNF\u2010alpha\u2010stimulated synthesis of PAI\u20101 in human endothelial cells. Indications that calcium acts at a translational level","volume":"17","author":"Peiretti","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.15162_bb0180","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1046\/j.1538-7836.2003.00443.x","article-title":"Activated protein C attenuates coagulation\u2010associated over\u2010expression of fibrinolytic activity by suppressing the thrombin\u2010dependent inactivation of PAI\u20101","volume":"1","author":"Urano","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15162_bb0185","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nri1269","article-title":"The dark side of C5a in sepsis","volume":"4","author":"Ward","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/jth.15162_bb0190","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.molimm.2009.11.001","article-title":"Silencing of C5a receptor gene with siRNA for protection from Gram\u2010negative bacterial lipopolysaccharide\u2010induced vascular permeability","volume":"47","author":"Liu","year":"2010","journal-title":"Mol Immunol"},{"key":"10.1111\/jth.15162_bb0195","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/joim.12331","article-title":"Endothelial barrier dysfunction in septic shock","volume":"277","author":"Opal","year":"2014","journal-title":"J Intern Med"},{"key":"10.1111\/jth.15162_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117261","article-title":"CD14 and complement crosstalk and largely mediate the transcriptional response to Escherichia coli in human whole blood as revealed by DNA microarray","volume":"10","author":"Lau","year":"2015","journal-title":"PLoS One"},{"key":"10.1111\/jth.15162_bb0205","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.4049\/jimmunol.1400341","article-title":"Double blockade of CD14 and complement C5 abolishes the cytokine storm and improves morbidity and survival in polymicrobial sepsis in mice","volume":"192","author":"Huber\u2010Lang","year":"2014","journal-title":"J Immunol"},{"key":"10.1111\/jth.15162_bb0210","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.it.2010.01.002","article-title":"Crosstalk pathways between Toll\u2010like receptors and the complement system","volume":"31","author":"Hajishengallis","year":"2010","journal-title":"Trends Immunol"},{"key":"10.1111\/jth.15162_bb0215","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/00000658-200211000-00013","article-title":"Novel approach to prevent the transition from the hyperdynamic phase to the hypodynamic phase of sepsis: role of adrenomedullin and adrenomedullin binding protein\u20101","volume":"236","author":"Yang","year":"2002","journal-title":"Ann Surg"},{"key":"10.1111\/jth.15162_bb0220","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.molimm.2019.03.014","article-title":"Phagocytosis of live and dead Escherichia coli and Staphylococcus aureus in human whole blood is markedly reduced by combined inhibition of C5aR1 and CD14","volume":"112","author":"Skjeflo","year":"2019","journal-title":"Mol Immunol"},{"key":"10.1111\/jth.15162_bb0225","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1177\/1753425913482993","article-title":"Post challenge inhibition of C3 and CD14 attenuates Escherichia coli\u2010induced inflammation in human whole blood","volume":"20","author":"Egge","year":"2014","journal-title":"Innate Immun"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15162","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.15162","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622006493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622006493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15162","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:31:45Z","timestamp":1761535905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622006493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S1538783622006493"],"URL":"https:\/\/doi.org\/10.1111\/jth.15162","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD14 inhibition improves survival and attenuates thrombo\u2010inflammation and cardiopulmonary dysfunction in a baboon model of Escherichia coli sepsis","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.15162","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}